Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33,061 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients.
Zazuli Z, Otten LS, Drögemöller BI, Medeiros M, Monzon JG, Wright GEB, Kollmannsberger CK, Bedard PL, Chen Z, Gelmon KA, McGoldrick N, Kitchlu A, Vijverberg SJH, Masereeuw R, Ross CJD, Liu G, Carleton BC, Maitland-van der Zee AH. Zazuli Z, et al. Among authors: liu g. Genes (Basel). 2019 May 10;10(5):364. doi: 10.3390/genes10050364. Genes (Basel). 2019. PMID: 31083486 Free PMC article.
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.
Bradbury PA, Kulke MH, Heist RS, Zhou W, Ma C, Xu W, Marshall AL, Zhai R, Hooshmand SM, Asomaning K, Su L, Shepherd FA, Lynch TJ, Wain JC, Christiani DC, Liu G. Bradbury PA, et al. Among authors: liu g. Pharmacogenet Genomics. 2009 Aug;19(8):613-25. doi: 10.1097/FPC.0b013e32832f3010. Pharmacogenet Genomics. 2009. PMID: 19620936 Free PMC article.
Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
Fehringer G, Liu G, Pintilie M, Sykes J, Cheng D, Liu N, Chen Z, Seymour L, Der SD, Shepherd FA, Tsao MS, Hung RJ. Fehringer G, et al. Among authors: liu n, liu g. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1097-104. doi: 10.1158/1055-9965.EPI-11-1123-T. Epub 2012 Apr 26. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22539604 Clinical Trial.
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.
Wong KM, Qiu X, Cheng D, Azad AK, Habbous S, Palepu P, Mirshams M, Patel D, Chen Z, Roberts H, Knox J, Marquez S, Wong R, Darling G, Waldron J, Goldstein D, Leighl N, Shepherd FA, Tsao M, Der S, Reisman D, Liu G. Wong KM, et al. Among authors: liu g. Cancer Med. 2014 Apr;3(2):426-33. doi: 10.1002/cam4.201. Epub 2014 Feb 12. Cancer Med. 2014. PMID: 24519853 Free PMC article.
Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ahmadizar F, Onland-Moret NC, de Boer A, Liu G, Maitland-van der Zee AH. Ahmadizar F, et al. Among authors: liu g. PLoS One. 2015 Oct 22;10(10):e0141704. doi: 10.1371/journal.pone.0141704. eCollection 2015. PLoS One. 2015. PMID: 26492353 Free PMC article. No abstract available.
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.
Cuffe S, Azad AK, Qiu X, Qiu X, Brhane Y, Kuang Q, Marsh S, Savas S, Chen Z, Cheng D, Leighl NB, Goss G, Laurie SA, Seymour L, Bradbury PA, Shepherd FA, Tsao MS, Chen BE, Xu W, Liu G. Cuffe S, et al. Among authors: liu g. Cancer Epidemiol. 2016 Apr;41:50-6. doi: 10.1016/j.canep.2015.12.012. Epub 2016 Jan 24. Cancer Epidemiol. 2016. PMID: 26816351
33,061 results
You have reached the last available page of results. Please see the User Guide for more information.